SRX Global Inc.
New York Stock Exchange ArcaRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- SRx Health Solutions Inc. SRx Health Solutions Inc. (SRXH) operates as an integrated healthcare services provider in the specialty pharmacy and pet health and wellness sectors across Canada and the United States. The company offers a comprehensive range of services including specialty pharmacy for complex and chronic disease management; infusion clinics and nursing for biologics, iron therapy, and injectable training; patient support programs; wholesale and pharmaceutical distribution from its Health Canada-accredited facility in Mississauga, Ontario; clinical trials sites; compounding services; retail pharmacy operations; travel health consultations with vaccinations and preventive medications; and pet products such as dry food, wet food, treats, supplements, dental products, chews, and vegan options under the Halo brand. With a national footprint in Canada encompassing 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, and an allied health team, SRx Health Solutions serves patients, hospitals, physicians, pharmaceutical manufacturers, and retailers targeting chronic, rare diseases, and everyday healthcare needs. Founded in 2013 and headquartered in Toronto, Canada, the company expanded significantly through its April 2025 business combination with Better Choice Company Inc., which resulted in a name change from Better Choice to SRx Health Solutions Inc., a stock split, rebranding, and NYSE American listing under ticker SRXH; this merger created a global health and wellness entity with projected 2025 revenues exceeding $270 million and positioned SRx securityholders to own approximately 85% of the combined company on a fully diluted basis.
Company News
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results
SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering
SRX Global Regains Full Compliance with NYSE American Listing Standards
SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding
SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1)
SRX Global Declares One-Time Cash Dividend
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines
SRX Global Announces Share Consolidation